James D. Perkins

Characterization of Interintestinal and Intraintestinal Variations in Human CYP3A-Dependent Metabolism

Mary F. Paine, Mehraneh Khalighi, Jeannine M. Fisher et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 791 citations

Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism*

Kenneth E. Thummel, Diarmuid O’Shea, Mary F. Paine et al. · Clinical Pharmacology & Therapeutics · 1996 · 616 citations

The Biopsied Donor Liver: Incorporating Macrosteatosis Into High-Risk Donor Assessment

Austin L. Spitzer, Oliver B. Lao, André A. S. Dick et al. · Liver Transplantation · 2010 · 337 citations · Full text

D-MELD, a Simple Predictor of Post Liver Transplant Mortality for Optimization of Donor/Recipient Matching

Jeffrey B. Halldorson, Ramasamy Bakthavatsalam, Oren K. Fix et al. · American Journal of Transplantation · 2008 · 317 citations · Full text

Transplant Rejection, Transplantation Surgery, Transplantation +14

First-pass metabolism of midazolam by the human intestine*

Mary F. Paine, Danny D. Shen, Kent L. Kunze et al. · Clinical Pharmacology & Therapeutics · 1996 · 304 citations

First-pass Metabolism, Gastrointestinal Pharmacology, Gastroenterology +17